Recruiting Safety and Feasibility of Nivolumab-IRDye800CW in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC) NCT07460765 Conditions Carcinoma, Carcinoma, Squamous Cell, HNSCC, +20 more Locations Vanderbilt University Medical Center — Nashville, Tennessee, United States View Trial Details
Recruiting Pilot Study of Bone Mineral Density Changes During Anti-PD-1 Immunotherapy NCT07555210 Conditions Adenocarcinoma, Breast Cancer (Triple Negative Breast Cancer (TNBC)), Breast Diseases, +44 more Locations Vanderbilt-Ingram Cancer Center — Nashville, Tennessee, United States View Trial Details
Not Yet Recruiting Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma NCT07127614 Conditions Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +7 more Locations AL Sayed Galal Hospital Al-Azhar University — Cairo, Egypt View Trial Details
Completed Sitravatinib (MGCD516) and Nivolumab in Oral Cavity Cancer Window Opportunity Study NCT03575598 Conditions Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +8 more Locations Princess Margaret Cancer Centre — Toronto, Ontario, Canada View Trial Details
